Pakistan has reached a historic milestone in advanced cancer treatment after the Armed Forces Bone Marrow Transplant Center (AFBMTC) in Rawalpindi successfully performed the country’s first CAR T-cell therapy. The groundbreaking procedure represents a significant advancement in Pakistan’s healthcare sector and offers new hope for patients battling aggressive blood cancers that do not respond to conventional treatments. Medical experts believe the achievement could transform cancer care by making highly specialized therapies available within the country.
The pioneering treatment was administered to a 21-year-old patient diagnosed with relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL), an aggressive form of blood cancer that had returned twice despite previous treatment. Patients with relapsed or refractory leukemia often have limited treatment options, making CAR T-cell therapy a promising alternative for improving outcomes in difficult cases.
According to the Armed Forces Bone Marrow Transplant Center, the patient received indigenously developed anti-CD19 CAR T-cell therapy on June 18, 2026. The treatment produced remarkable results, with the patient achieving measurable residual disease (MRD)-negative complete remission by the 14th day following the procedure. After responding well to treatment, the patient was discharged from the hospital on July 3, 2026.
CAR T-cell therapy is regarded as one of the world’s most advanced forms of cancer treatment. The procedure involves modifying a patient’s own immune cells to recognize and destroy cancer cells more effectively. Although the therapy has shown impressive success in treating certain blood cancers internationally, its availability has remained limited due to its complexity, high cost, and specialized infrastructure requirements. Pakistan’s successful implementation marks a major breakthrough in the country’s medical capabilities.
The AFBMTC credited the achievement to years of dedicated planning and collaboration by its physicians, apheresis and cell-processing scientists, laboratory experts, and nursing staff working under the Army Medical Corps. The center also praised the courage and trust demonstrated by the patient and his family for agreeing to undergo the country’s first locally developed CAR T-cell therapy, paving the way for future patients.
The successful procedure is expected to open new opportunities for cellular and immune-effector therapies in Pakistan. Healthcare experts believe this milestone could enable more cancer patients to access cutting-edge treatment without traveling abroad, strengthening the country’s ability to provide world-class medical care while advancing research and innovation in oncology.
Also read: Silent Mouth Threat: Recognize Oral Cancer Warning Signs
